<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">37790031</PMID><DateRevised><Year>2023</Year><Month>10</Month><Day>05</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2168-8184</ISSN><JournalIssue CitedMedium="Print"><Volume>15</Volume><Issue>9</Issue><PubDate><Year>2023</Year><Month>Sep</Month></PubDate></JournalIssue><Title>Cureus</Title><ISOAbbreviation>Cureus</ISOAbbreviation></Journal><ArticleTitle>A Case of Angioimmunoblastic T-Cell Lymphoma and the Difficulties of Diagnosis.</ArticleTitle><Pagination><StartPage>e44566</StartPage><MedlinePgn>e44566</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">e44566</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.7759/cureus.44566</ELocationID><Abstract><AbstractText>Angioimmunoblastic T-cell lymphoma (AITL) is a rare and aggressive form of peripheral T-cell lymphoma (PTCL). It can present with signs and symptoms that have broad differentials, including fevers, night sweats, and skin rashes. In this case report, we present an interesting case of a young male of Nigerian descent with recently treated malaria who presented with such symptoms and a picture that was complicated, due to an inconclusive excisional biopsy for lymphoma. He was later diagnosed with AITL. Given the patient's recent exposure to malaria, we will discuss the potential role malaria has in the development of AITL.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023, Koifman et al.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Koifman</LastName><ForeName>Michelle</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Internal Medicine, The Brooklyn Hospital Center, Brooklyn, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tai</LastName><ForeName>Waqqas</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Internal Medicine, The Brooklyn Hospital Center, Brooklyn, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castro</LastName><ForeName>Daniel</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Hemotolgy and Oncology, The Brooklyn Hospital Center, Brooklyn, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ahluwalia</LastName><ForeName>Amith</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Hematology and Oncology, The Brooklyn Hospital Center, Brooklyn, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Yingxian</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Pathology, The Brooklyn Hospital Center, Brooklyn, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D002363">Case Reports</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>09</Month><Day>02</Day></ArticleDate></Article><MedlineJournalInfo><Country>United States</Country><MedlineTA>Cureus</MedlineTA><NlmUniqueID>101596737</NlmUniqueID><ISSNLinking>2168-8184</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">aitl</Keyword><Keyword MajorTopicYN="N">axillary lymphadenopathy</Keyword><Keyword MajorTopicYN="N">chop</Keyword><Keyword MajorTopicYN="N">malaria</Keyword><Keyword MajorTopicYN="N">non-hodgkin lymphoma (nhl)</Keyword></KeywordList><CoiStatement>The authors have declared that no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>45</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>4</Day><Hour>6</Hour><Minute>44</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>4</Day><Hour>3</Hour><Minute>57</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37790031</ArticleId><ArticleId IdType="pmc">PMC10544870</ArticleId><ArticleId IdType="doi">10.7759/cureus.44566</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>No survival improvement for patients with angioimmunoblastic T-cell lymphoma over the past two decades: a population-based study of 1207 cases. Xu B, Liu P. PLoS One. 2014;9:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3961418</ArticleId><ArticleId IdType="pubmed">24651162</ArticleId></ArticleIdList></Reference><Reference><Citation>Rangoonwala HI, Cascella M. StatPearls. Treasure Island, FL: StatPearls Publishing; 2022. Peripheral T-cell lymphoma.</Citation><ArticleIdList><ArticleId IdType="pubmed">32965972</ArticleId></ArticleIdList></Reference><Reference><Citation>How I diagnose angioimmunoblastic T-cell lymphoma. Xie Y, Jaffe ES. Am J Clin Pathol. 2021;156:1&#x2013;14.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8209595</ArticleId><ArticleId IdType="pubmed">34117736</ArticleId></ArticleIdList></Reference><Reference><Citation>Angioimmunoblastic T-cell lymphoma mimicking drug fever and infectious etiology after a thyroidectomy: A case report. Han P, Yang L, Yan W, Tian D. Medicine (Baltimore) 2019;98:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6716746</ArticleId><ArticleId IdType="pubmed">31441883</ArticleId></ArticleIdList></Reference><Reference><Citation>Spectrum of bone marrow findings in patients with angioimmunoblastic T-cell lymphoma. Grogg KL, Morice WG, Macon WR. Br J Haematol. 2007;137:416&#x2013;422.</Citation><ArticleIdList><ArticleId IdType="pubmed">17488486</ArticleId></ArticleIdList></Reference><Reference><Citation>Not your typical morbilliform rash: Angioimmunoblastic T-cell lymphoma. Bao W, Buchanan KL, Davis LS. Clin Case Rep. 2021;9:4367.</Citation></Reference><Reference><Citation>Angioimmunoblastic T-cell lymphoma accompanied by pure red cell aplasia: A case report. Kawahigashi T, Kitagawa I, Tanaka E. World J Clin Oncol. 2020;11:405&#x2013;411.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7450812</ArticleId><ArticleId IdType="pubmed">32874954</ArticleId></ArticleIdList></Reference><Reference><Citation>Upfront VIP-reinforced-ABVD (VIP-rABVD) is not superior to CHOP/21 in newly diagnosed peripheral T cell lymphoma. Results of the randomized phase III trial GOELAMS-LTP95. Simon A, Peoch M, Casassus P, et al. Br J Haematol. 2010;151:159&#x2013;166.</Citation><ArticleIdList><ArticleId IdType="pubmed">20738307</ArticleId></ArticleIdList></Reference><Reference><Citation>Up-front autologous stem-cell transplantation in peripheral T-cell lymphoma: NLG-T-01. d'Amore F, Relander T, Lauritzsen GF, et al. J Clin Oncol. 2012;30:3093&#x2013;3099.</Citation><ArticleIdList><ArticleId IdType="pubmed">22851556</ArticleId></ArticleIdList></Reference><Reference><Citation>Bevacizumab and cyclosphosphamide, doxorubicin, vincristine and prednisone in combination for patients with peripheral T-cell or natural killer cell neoplasms: an Eastern Cooperative Oncology Group study (E2404) Ganjoo K, Hong F, Horning SJ, et al. Leuk Lymphoma. 2014;55:768&#x2013;772.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3872505</ArticleId><ArticleId IdType="pubmed">23786456</ArticleId></ArticleIdList></Reference><Reference><Citation>Cardiac toxicity associated with bevacizumab (Avastin) in combination with CHOP chemotherapy for peripheral T cell lymphoma in ECOG 2404 trial. Advani RH, Hong F, Horning SJ, et al. Leuk Lymphoma. 2012;53:718&#x2013;720.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3919492</ArticleId><ArticleId IdType="pubmed">21916830</ArticleId></ArticleIdList></Reference><Reference><Citation>Alemtuzumab (Campath-1H) and CHOP chemotherapy as first-line treatment of peripheral T-cell lymphoma: results of a GITIL (Gruppo Italiano Terapie Innovative nei Linfomi) prospective multicenter trial. Gallamini A, Zaja F, Patti C, et al. Blood. 2007;110:2316&#x2013;2323.</Citation><ArticleIdList><ArticleId IdType="pubmed">17581918</ArticleId></ArticleIdList></Reference><Reference><Citation>Alemtuzumab and CHOP chemotherapy for the treatment of aggressive histology peripheral T cell lymphomas: a multi-center phase I study. Buckstein R, Fraser G, Cheung M, et al. Clin Lymphoma Myeloma Leuk. 2016;16:18&#x2013;28.</Citation><ArticleIdList><ArticleId IdType="pubmed">26711181</ArticleId></ArticleIdList></Reference><Reference><Citation>Malaria and risk of lymphoid neoplasms and other cancer: a nationwide population-based cohort study. Wyss K, Granath F, W&#xe5;ngdahl A, Dj&#xe4;rv T, Fored M, Naucler P, F&#xe4;rnert A. BMC Med. 2020;18:296.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7596993</ArticleId><ArticleId IdType="pubmed">33121475</ArticleId></ArticleIdList></Reference><Reference><Citation>Acute malaria induces PD1+CTLA4+ effector T cells with cell-extrinsic suppressor function. Mackroth MS, Abel A, Steeg C, Schulze Zur Wiesch J, Jacobs T. PLoS Pathog. 2016;12:0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5089727</ArticleId><ArticleId IdType="pubmed">27802341</ArticleId></ArticleIdList></Reference><Reference><Citation>Increased serum level of interleukin-10 predicts poor survival and early recurrence in patients with peripheral T-cell lymphomas. Zhang Y, Zheng Y, Shou L, et al. Front Oncol. 2020;10:584261.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7590574</ArticleId><ArticleId IdType="pubmed">33154947</ArticleId></ArticleIdList></Reference><Reference><Citation>Elevated serum interleukin-10 level and M2 macrophage infiltration are associated with poor survival in angioimmunoblastic T-cell lymphoma. Ham JS, Park HY, Ryu KJ, Ko YH, Kim WS, Kim SJ. Oncotarget. 2017;8:76231&#x2013;76240.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5652701</ArticleId><ArticleId IdType="pubmed">29100307</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>